Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial (Q82640441)
Jump to navigation
Jump to search
scientific article published on 01 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial |
scientific article published on 01 February 2012 |
Statements
Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial (English)
Matthew A Cavender
Gregory Schwartz
David D Waters
Robert S Rosenson
Dianna Bash
1 February 2012